# Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease

> **NCT06381518** · NA · COMPLETED · sponsor: **Zuyderland Medisch Centrum** · enrollment: 38 (actual)

## Conditions studied

- IBD
- Infliximab
- Crohn Disease
- Ulcerative Colitis

## Interventions

- **OTHER:** Switch to SC CT-P13.

## Key facts

- **NCT ID:** NCT06381518
- **Lead sponsor:** Zuyderland Medisch Centrum
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-12
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-12-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06381518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06381518, "Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06381518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*